Vol 9 Issue 10

CELL AND GENE THERAPY INSIGHTS

Vol 9 Issue 10

Cell and Gene Therapy Insights Vol 9 Issue 10

Download PDF

Featuring

Issue Spotlight: Cell therapy downstream processing & CMC
Navigating the final mile: How to ensure the healthcare sector are prepared to deliver the commercial cell and gene therapies of tomorrow to patients? 2023
Other articles
Webinars

Cell therapy downstream processing & CMC

Innovator Insight

Empowering the future of cell therapy: leveraging partnerships to support advancement

Empowering the future of cell therapy: leveraging partnerships to support advancement

J Patarroyo, F Mack, X de Mollerat du Jeu et al.

23 November 2023

Interview

Key considerations in expanding global manufacture of a commercialized CAR-T cell therapy

Key considerations in expanding global manufacture of a commercialized CAR-T cell therapy

30 November 2023

Enabling patient access to CAR-T cell therapy in India

Enabling patient access to CAR-T cell therapy in India

Shashwati Basak

22 November 2023

Addressing the risk presented by extractables and leachables in cell therapy manufacturing

Addressing the risk presented by extractables and leachables in cell therapy manufacturing

28 September 2023

Expert Roundtable

Current issues & future trends in cryopreservation for advanced therapies

Current issues & future trends in cryopreservation for advanced therapies

Jason Acker, Allison Hubel, Sean Werner

20 December 2023

Infographic

Exosome manufacturing: INFOGRAPHIC

Exosome manufacturing: INFOGRAPHIC

Navigating the final mile: How to ensure the healthcare sector are prepared to deliver the commercial cell and gene therapies of tomorrow to patients? 2023

Viewpoint

Navigating the final mile: how are hospitals providing capabilities for commercial cell therapy product delivery?

Navigating the final mile: how are hospitals providing capabilities for commercial cell therapy product delivery?

Alexey Bersenev

29 November 2023

Navigating the final mile: how are Australian hospitals delivering autologous cell & gene therapies?

Navigating the final mile: how are Australian hospitals delivering autologous cell & gene therapies?

Sharon Sagnella

10 November 2023

Journal articles

Commentary

Building rings with spheres: a cell therapy approach to incontinence

Building rings with spheres: a cell therapy approach to incontinence

M Gilbert, S Čaputová, D Poli et al.

7 December 2023

FastFacts

HEK293 suspension culture in stirred 3D-systems for gene therapy development

HEK293 suspension culture in stirred 3D-systems for gene therapy development

14 November 2023

Automating the cell therapy workflow with Gibco<sup>TM</sup> CTS<sup>TM</sup> Cellmation<sup>TM</sup> Software for DeltaV<sup>TM</sup> System

Automating the cell therapy workflow with Gibco^TM CTS^TM Cellmation^TM Software for DeltaV^TM System

Elizabeth Wahl, Prajakta Bhanap

9 November 2023

Cell culture in a chemically defined environment

Cell culture in a chemically defined environment

Chengkang Zhang

29 November 2023

Reliable detection reagents in CAR-T/NK cell flow cytometry

Reliable detection reagents in CAR-T/NK cell flow cytometry

17 November 2023

Case study: media optimization control strategies

Case study: media optimization control strategies

17 November 2023

Webinar Digest

Three distinct analytical ultracentrifugation methods for virus and viral vector characterizations

Three distinct analytical ultracentrifugation methods for virus and viral vector characterizations

Susumu Uchiyama

29 November 2023

Unlocking allogeneic cell therapy success: downstream strategies for commercialization

Unlocking allogeneic cell therapy success: downstream strategies for commercialization

J Lee, T Nanda, N Tyagi

17 October 2023

A deep dive into optimizing AAV capture and polishing to maximize both yield and purity

A deep dive into optimizing AAV capture and polishing to maximize both yield and purity

Åsa Hagner-McWhirter

1 November 2023

Isolating CD4+ and CD8+ T cells for improved drug efficacy and increased productivity

Isolating CD4+ and CD8+ T cells for improved drug efficacy and increased productivity

2 November 2023

Strategic raw material selection for cell therapy commercialization

Strategic raw material selection for cell therapy commercialization

K Kime, L Belcastro, K Hondorp

9 November 2023

Pioneering the development of point-of-care CAR T cell therapy manufacturing in Canada: experience from the CLIC-01 CD19 CAR T clinical trial

Pioneering the development of point-of-care CAR T cell therapy manufacturing in Canada: experience from the CLIC-01 CD19 CAR T clinical trial

Natasha Kekre

14 November 2023

Closed system solutions for cell and gene therapy manufacturing

Closed system solutions for cell and gene therapy manufacturing

Anette Funfak

15 November 2023

The future of RNA-lipid nanoparticles for CAR-T cell therapy development

The future of RNA-lipid nanoparticles for CAR-T cell therapy development

Samuel Clarke

16 November 2023

De-risking cell therapy product development: strategies for commercial success

De-risking cell therapy product development: strategies for commercial success

Chad Andersen, Alex Sargent

20 November 2023

iPSC-ing into the future of cell therapy: expansion in a hollow-fiber bioreactor

iPSC-ing into the future of cell therapy: expansion in a hollow-fiber bioreactor

Nathan Frank, Molly Tregidgo

21 November 2023

Pairing a novel enhancer with transfection reagents to enable high-titer rAAV production

Pairing a novel enhancer with transfection reagents to enable high-titer rAAV production

F Dziopa, R Gantier, B Reese

28 November 2023

How to apply quality by design principles to cell and gene therapy release testing

How to apply quality by design principles to cell and gene therapy release testing

Audrey Chang

30 November 2023